Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

4.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

24.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
12.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
1.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Reply Letter to negative findings of short-term isolated leucine supplementation in head and neck cancer: Intervention failure or insufficient anabolic context?"

Clinical nutrition ESPEN·2026
Same author

Disuse-Induced Muscle Atrophy and Muscle Weakness From Hospitalization to Spaceflight: Exercise Succeeds in Prevention and Treatment-A Meta-Analysis.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Short-term isolated leucine supplementation was not associated with improvements in muscle mass or function in patients with head and neck cancer: A randomized, double-blind, proof-of-concept trial with an elderly non-cancer comparator cohort.

Clinical nutrition ESPEN·2026
Same author

Cancer-Associated Cachexia in the Era of Obesity.

International journal of molecular sciences·2025
Same author

Oxytocin treatment reduces cancer cachexia in a pre-clinical model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Functional and in silico evidence for the role of microRNAs 148a-5p and 199a in migration and invasion of papillary thyroid carcinoma cells.

Discover oncology·2025

Related Experiment Video

Updated: Mar 31, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.4K

Cancer Cachexia and MicroRNAs.

Rodolfo Gonzalez Camargo1, Henrique Quintas Teixeira Ribeiro2, Murilo Vieira Geraldo3

  • 1Cancer Metabolism Research Group, Institute of Biomedical Sciences, University of São Paulo, Avenida Professor Lineu Prestes 1524, Cidade Universitária, 05508-000 São Paulo, SP, Brazil ; NAPmiR-miRNA Research Group, University of São Paulo, Avenida Professor Lineu Prestes 1524, Cidade Universitária, 05508-000 São Paulo, SP, Brazil.

Mediators of Inflammation
|October 28, 2015
PubMed
Summary

MicroRNAs (miRNAs) may play a role in cancer cachexia, a syndrome causing weight loss and fatigue. Understanding these molecules could improve diagnosis and treatment for this complex condition.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Experiment Videos

Last Updated: Mar 31, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.4K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Cancer cachexia is a paraneoplastic syndrome characterized by involuntary weight loss, fatigue, and systemic inflammation, significantly impacting patient survival and quality of life.
  • It arises from complex tumor-host interactions, with systemic inflammation being a critical factor in its progression.
  • The precise mechanisms driving cachexia and the release of inflammatory cytokines remain incompletely understood, highlighting the need for further research.

Purpose of the Study:

  • To explore the potential role of microRNAs (miRNAs) in modulating the host inflammatory response within the context of cancer cachexia.
  • To emphasize the importance of establishing robust evidence regarding miRNAs and cachexia mechanisms for improved diagnosis and treatment.

Main Methods:

  • This study proposes a theoretical framework based on existing literature regarding miRNA function and cancer cachexia.
  • It reviews the known roles of miRNAs in regulating gene expression, adipose and skeletal muscle metabolism, and inflammation in cancer.
  • The focus is on the potential of miRNAs to influence the inflammatory pathways central to cachexia.

Main Results:

  • MicroRNAs (miRNAs) are noncoding RNAs with diverse expression profiles linked to various diseases and inflammatory processes.
  • miRNAs have been shown to modulate metabolism in adipose and skeletal muscle tissues and influence inflammation in cancer cachexia.
  • A potential role for miRNAs in regulating the host inflammatory response during cancer cachexia is proposed.

Conclusions:

  • MicroRNAs (miRNAs) are implicated in modulating key aspects of cancer cachexia, including tissue metabolism and inflammation.
  • Further investigation into the specific roles and mechanisms of miRNAs in cancer cachexia is essential.
  • Establishing a strong body of evidence for miRNAs in cachexia pathogenesis will be crucial for advancing diagnostic and therapeutic strategies.